Public Hospital District 1 of King County

Public Hospital District 1 of King County was paid $120.79M by Medicaid between Jan 2018 and Dec 2024, across 616 billing codes. Its largest line is G0463, Hospital outpatient clinic visit for assessment and management of a patient — 32% of everything it billed.

33Billing provider infoPUBLIC HOSPITAL DISTRICT 1 OF KING COUNTY
RENTON, WA 98055

33aNPI1649209230assigned 07/03/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$120.79M

24GClaims3,297,518

24DCodes billed616

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Washington

Rank by total paid#3 of 49

Median peer was paid$20.06M

This provider vs. median6.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	445,865	$17.92M
2019	456,975	$17.98M
2020	422,037	$16.04M
2021	499,807	$18.03M
2022	519,224	$18.14M
2023	513,761	$17.56M
2024incomplete	439,849	$15.12M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0463	Hospital outpatient clinic visit for assessment and management of a patient	32%	418,964	336,809	$38.13M
96361	Intravenous infusion, hydration; each additional hour	10%	44,807	38,006	$12.58M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	6.3%	71,945	67,935	$7.64M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	3.6%	72,605	66,672	$4.30M
99282	Emergency department visit for the evaluation and management, low to moderate severity	3.5%	37,814	35,976	$4.22M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.6%	50,924	47,022	$3.09M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.9%	16,205	15,470	$2.25M
70450	Computed tomography, head or brain; without contrast material	1.6%	16,273	15,349	$1.99M
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.5%	43,889	18,730	$1.83M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.5%	15,556	14,355	$1.76M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.3%	8,748	5,483	$1.55M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	1.3%	34,820	13,878	$1.54M

604 more codes

96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.3%	18,622	$1.54M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.1%	29,550	$1.36M
59025	Fetal non-stress test	1.1%	9,387	$1.35M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.0%	17,817	$1.25M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	4,044	$1.19M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,888	$1.10M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	3,217	$1.09M
J9271	Injection, pembrolizumab, 1 mg	<1%	267	$1.01M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	6,259	$1.00M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	50,862	$988K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	1,528	$765K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	9,142	$734K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	3,569	$722K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,099	$717K
76830	Ultrasound, transvaginal	<1%	8,380	$701K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	3,917	$636K
77412		<1%	1,380	$623K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	3,096	$584K
96415		<1%	3,080	$550K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,735	$538K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	488	$505K
76801		<1%	9,069	$483K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	22,962	$470K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	9,438	$462K
80053	Comprehensive metabolic panel	<1%	111,222	$427K
76642		<1%	4,769	$420K
17110		<1%	1,910	$410K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	7,966	$384K
95886		<1%	2,593	$368K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	3,183	$365K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	5,564	$364K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,191	$364K
95806		<1%	712	$355K
12001		<1%	1,877	$355K
29125		<1%	2,449	$343K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	6,423	$325K
12011		<1%	1,492	$314K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	22,477	$308K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	46,005	$305K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	4,664	$305K
90651		<1%	4,133	$304K
77063	Screening digital breast tomosynthesis, bilateral	<1%	8,858	$293K
70496		<1%	2,251	$293K
10060		<1%	1,609	$285K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	580	$281K
76770		<1%	3,354	$280K
76536		<1%	3,416	$274K
29515		<1%	1,965	$273K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,220	$273K
20611		<1%	1,531	$250K
97129		<1%	892	$242K
95812		<1%	684	$228K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,323	$214K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,069	$205K
97161		<1%	5,435	$204K
93970		<1%	2,261	$192K
10061		<1%	889	$191K
93017		<1%	2,041	$190K
12002		<1%	1,093	$185K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	3,931	$180K
49083		<1%	663	$172K
71046	Radiologic examination, chest; 2 views	<1%	25,961	$169K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	417	$164K
96367		<1%	4,368	$164K
Q3014	Telehealth originating site facility fee	<1%	6,604	$161K
72141		<1%	1,289	$160K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	1,775	$158K
95800		<1%	1,253	$155K
52000		<1%	322	$149K
90686		<1%	18,943	$148K
78815	Positron emission tomography (PET) for limited area imaging	<1%	322	$144K
90715		<1%	8,524	$140K
29505		<1%	1,081	$140K
97113		<1%	3,334	$138K
64615		<1%	563	$136K
76870		<1%	1,594	$136K
G0378	Hospital observation service, per hour	<1%	16,897	$133K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	883	$130K
71250		<1%	2,710	$125K
36902		<1%	166	$118K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	4,352	$116K
J0897	Injection, denosumab, 1 mg	<1%	880	$116K
97162		<1%	3,331	$115K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	910	$111K
76819	Fetal biophysical profile; without non-stress testing	<1%	2,708	$109K
80048	Basic metabolic panel (calcium, ionized)	<1%	29,863	$108K
70491		<1%	950	$105K
84484		<1%	27,464	$105K
36430		<1%	1,386	$102K
74183		<1%	604	$101K
70486		<1%	2,684	$95K
J1756	Injection, iron sucrose, 1 mg	<1%	4,379	$93K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	11,587	$90K
97535	Self-care/home management training, each 15 minutes	<1%	5,306	$86K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	1,316	$82K
76942		<1%	1,548	$81K
90750		<1%	732	$80K
76882		<1%	1,148	$80K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	14,386	$77K
77066	Tomosynthesis, mammo	<1%	3,059	$76K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	6,364	$69K
76813		<1%	2,085	$68K
94060		<1%	1,906	$67K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	31,600	$65K
97116		<1%	5,952	$65K
97165		<1%	2,017	$64K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	9,127	$62K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	52,923	$61K
73630		<1%	7,974	$60K
77080		<1%	1,990	$59K
87040		<1%	8,476	$57K
90674		<1%	3,330	$57K
76937		<1%	2,433	$57K
36415	Collection of venous blood by venipuncture	<1%	151,302	$57K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	48,097	$56K
93971		<1%	813	$55K
77336		<1%	1,237	$54K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,093	$53K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,171	$52K
70498		<1%	2,191	$52K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	4,756	$52K
90647		<1%	3,978	$52K
90472	Immunization administration, each additional vaccine (list separately)	<1%	14,443	$51K
20610		<1%	427	$50K
77065	Tomosynthesis, mammo	<1%	1,978	$50K
99001		<1%	14,890	$49K
90670		<1%	5,865	$49K
71271		<1%	944	$47K
72125	Computed tomography, cervical spine; without contrast material	<1%	4,761	$47K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	125,330	$47K
72100		<1%	5,092	$47K
47562		<1%	24	$47K
93978		<1%	1,248	$46K
95816		<1%	301	$45K
73030		<1%	5,593	$41K
44970		<1%	13	$40K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	<1%	47	$39K
72040		<1%	2,369	$39K
73560		<1%	1,938	$37K
83605		<1%	7,725	$36K
97763		<1%	409	$35K
73610		<1%	5,898	$35K
29540		<1%	295	$35K
73564		<1%	6,324	$35K
J3490	Unclassified drugs	<1%	2,752	$34K
74018		<1%	3,776	$34K
83880		<1%	9,371	$34K
73130		<1%	5,130	$32K
64405		<1%	123	$30K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,097	$30K
71045	Radiologic examination, chest; single view	<1%	24,505	$29K
94726		<1%	1,779	$28K
94729		<1%	1,844	$28K
85380		<1%	5,781	$28K
93798		<1%	4,362	$27K
72110		<1%	1,228	$27K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	506	$27K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	148	$26K
76820		<1%	821	$25K
90734		<1%	2,116	$25K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	14	$24K
64450		<1%	227	$24K
73110		<1%	3,781	$23K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	4,095	$23K
96523		<1%	807	$22K
73502		<1%	3,069	$20K
36591		<1%	2,802	$19K
90714		<1%	955	$18K
0134A		<1%	692	$18K
72193		<1%	90	$18K
0071A		<1%	462	$18K
84145		<1%	2,255	$18K
90677		<1%	1,579	$18K
0054A		<1%	663	$18K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	57	$18K
97035		<1%	2,785	$18K
72072		<1%	1,372	$17K
36475		<1%	15	$17K
11900		<1%	113	$17K
90688		<1%	1,045	$17K
29105		<1%	83	$16K
82728		<1%	3,925	$16K
64616		<1%	60	$16K
76818		<1%	423	$16K
0072A		<1%	382	$15K
29240		<1%	83	$15K
95819		<1%	50	$15K
96375	Therapeutic injection; each additional sequential IV push	<1%	41,494	$15K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	<1%	27	$15K
74174		<1%	265	$15K
73140		<1%	2,551	$15K
97166		<1%	437	$14K
72156		<1%	141	$14K
69209		<1%	358	$14K
88307		<1%	1,316	$13K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	108	$13K
90707		<1%	1,551	$13K
72050		<1%	938	$13K
73080		<1%	2,394	$13K
85027		<1%	23,254	$13K
29130		<1%	80	$12K
64644		<1%	354	$12K
72197		<1%	51	$12K
0064A		<1%	499	$12K
58300		<1%	93	$12K
97803		<1%	391	$11K
77001		<1%	252	$11K
G0105	Colorectal cancer screening; colonoscopy on individual at high risk	<1%	28	$11K
0004A		<1%	416	$10K
95909		<1%	477	$10K
76857		<1%	136	$10K
73590		<1%	2,092	$10K
51710		<1%	141	$10K
70544		<1%	45	$10K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	193	$10K
95811		<1%	24	$9K
19083		<1%	15	$9K
76821		<1%	269	$9K
0124A		<1%	412	$9K
86300		<1%	1,593	$9K
29530		<1%	51	$9K
0001A		<1%	243	$8K
92557		<1%	149	$8K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	91	$8K
90685		<1%	443	$8K
86923		<1%	1,220	$8K
97760		<1%	303	$8K
51705		<1%	102	$7K
51102		<1%	19	$7K
73221		<1%	55	$7K
84466		<1%	3,512	$7K
82962		<1%	40,096	$7K
74178		<1%	40	$7K
J3489	Injection, zoledronic acid, 1 mg	<1%	724	$7K
71101		<1%	1,440	$7K
82784		<1%	1,164	$7K
31575		<1%	27	$7K
97163		<1%	197	$7K
95700		<1%	78	$6K
0011A		<1%	200	$6K
83540		<1%	3,529	$6K
51702		<1%	1,422	$6K
82247		<1%	2,153	$6K
72202		<1%	438	$6K
73660		<1%	1,192	$6K
99490	Ccm add 20min	<1%	458	$6K
90746		<1%	294	$6K
0012A		<1%	163	$6K
29580		<1%	26	$6K
64643		<1%	56	$6K
73700		<1%	107	$6K
96402		<1%	1,163	$6K
90656		<1%	1,264	$5K
J0185	Injection, aprepitant, 1 mg	<1%	66	$5K
83735		<1%	15,167	$5K
97018		<1%	2,364	$5K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	22,248	$5K
69210		<1%	163	$5K
20552		<1%	46	$5K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	25	$5K
11100		<1%	13	$5K
73090		<1%	1,437	$5K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	15,738	$5K
85018		<1%	4,303	$5K
81001		<1%	32,777	$5K
0002A		<1%	136	$5K
83690		<1%	32,170	$5K
73562		<1%	297	$5K
82553		<1%	1,061	$5K
84703		<1%	20,887	$5K
58301		<1%	40	$4K
97802		<1%	87	$4K
90713		<1%	317	$4K
84702		<1%	6,605	$4K
85610		<1%	36,837	$4K
77290		<1%	21	$4K
82378		<1%	1,970	$4K
82607		<1%	1,345	$4K
10005		<1%	13	$4K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	30,428	$4K
81003		<1%	25,786	$4K
20550		<1%	14	$4K
84443	Thyroid stimulating hormone (TSH)	<1%	5,735	$4K
64400		<1%	16	$3K
87086	Culture, bacterial; quantitative colony count, urine	<1%	15,922	$3K
11721		<1%	173	$3K
81025		<1%	16,893	$3K
92083		<1%	67	$3K
96416		<1%	109	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	4,759	$3K
77334		<1%	78	$3K
12013		<1%	12	$3K
92567		<1%	316	$3K
86334		<1%	939	$3K
82248		<1%	2,965	$3K
92523		<1%	24	$3K
97130		<1%	783	$3K
74220		<1%	90	$3K
36592		<1%	5,598	$3K
86580		<1%	427	$3K
0051A		<1%	78	$3K
87070		<1%	3,825	$2K
86850		<1%	4,069	$2K
0052A		<1%	67	$2K
11102		<1%	12	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	9,547	$2K
82565		<1%	4,687	$2K
11982		<1%	12	$2K
88185		<1%	110	$2K
77280		<1%	12	$2K
70360		<1%	135	$2K
86140		<1%	4,600	$2K
86900		<1%	4,628	$2K
90732		<1%	483	$2K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	399	$2K
90694		<1%	2,087	$2K
96376		<1%	14,186	$2K
J1750	Injection, iron dextran, 50 mg	<1%	44	$2K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	10,525	$2K
77300		<1%	31	$2K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	75	$2K
A9585	Injection, gadobutrol, 0.1 ml	<1%	6,581	$2K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,811	$2K
87081		<1%	4,131	$2K
72170		<1%	217	$2K
83615		<1%	1,527	$2K
83521		<1%	784	$2K
99495		<1%	121	$2K
86901		<1%	7,498	$2K
77077		<1%	132	$2K
84165		<1%	972	$1K
0144A		<1%	38	$1K
73060		<1%	463	$1K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	22,228	$1K
99152		<1%	3,897	$1K
73552		<1%	387	$1K
96417		<1%	2,593	$1K
84100		<1%	3,767	$1K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,009	$1K
83883		<1%	143	$1K
81002		<1%	13,474	$1K
36416		<1%	11,265	$1K
91321		<1%	55	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	41,992	$1K
J2704	Injection, propofol, 10 mg	<1%	23,019	$1K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	763	$1K
96401		<1%	160	$1K
95910		<1%	61	$1K
92133		<1%	568	$1K
84439		<1%	1,164	$1K
90480		<1%	90	$983.52
82550		<1%	2,771	$971.12
84153		<1%	847	$970.94
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	21,806	$967.45
84155		<1%	2,293	$963.55
0074A		<1%	23	$929.60
85730		<1%	6,833	$922.06
85007		<1%	3,798	$873.05
90474		<1%	2,805	$830.43
J2997	Injection, alteplase recombinant, 1 mg	<1%	28	$820.40
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	13	$796.57
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	380	$750.00
82803		<1%	2,450	$735.14
85652		<1%	3,440	$732.09
64447		<1%	40	$727.14
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	973	$719.71
87186		<1%	4,724	$696.67
51798		<1%	1,575	$689.43
87205		<1%	3,620	$683.09
87210		<1%	3,405	$668.49
92136		<1%	44	$658.39
0111A		<1%	17	$652.00
74230		<1%	13	$651.75
J2785	Injection, regadenoson, 0.1 mg	<1%	815	$644.82
90700		<1%	2,043	$632.66
73523		<1%	36	$632.40
90662		<1%	682	$632.10
J2270	Injection, morphine sulfate, up to 10 mg	<1%	11,974	$614.90
97597		<1%	14	$587.18
82746		<1%	299	$574.54
0112A		<1%	13	$569.20
88184		<1%	125	$564.24
76981		<1%	14	$541.49
80061	Lipid panel	<1%	570	$536.34
0141A		<1%	13	$516.40
V2632	Posterior chamber intraocular lens	<1%	156	$485.98
88342		<1%	2,507	$478.13
88304		<1%	2,680	$472.77
80177		<1%	271	$469.99
97012		<1%	70	$465.91
80051		<1%	766	$464.51
87088		<1%	3,090	$454.22
0053A		<1%	17	$450.80
90710		<1%	2,235	$448.78
91322		<1%	13	$440.60
87340		<1%	653	$425.38
72052		<1%	18	$424.21
90633		<1%	3,651	$407.99
87147		<1%	1,838	$380.62
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	1,706	$367.02
87077		<1%	2,196	$359.23
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	57	$357.84
97750		<1%	44	$353.15
84550		<1%	1,889	$349.94
90716		<1%	1,590	$341.11
94664		<1%	69	$338.83
85014		<1%	1,049	$330.89
84156		<1%	948	$314.93
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	3,152	$312.13
74022		<1%	65	$310.58
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	14	$307.58
84132		<1%	2,841	$304.56
99153	Mod sedat endo service >5yrs	<1%	2,051	$283.56
82040		<1%	1,000	$269.67
92134		<1%	247	$268.20
J2550	Injection, promethazine hcl, up to 50 mg	<1%	2,748	$265.74
J1170	Injection, hydromorphone, up to 4 mg	<1%	15,726	$260.83
82010		<1%	1,523	$253.03
97014		<1%	24	$239.03
85046		<1%	241	$233.67
86304		<1%	70	$230.97
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	11,164	$229.88
82570		<1%	1,000	$227.17
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,939	$225.08
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	22,445	$223.49
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,258	$214.55
92610		<1%	13	$214.50
80076		<1%	76	$208.06
82947		<1%	888	$195.32
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	296	$181.81
95874		<1%	1,056	$169.00
85520		<1%	930	$155.99
74021		<1%	32	$147.48
84460		<1%	909	$146.54
84450		<1%	910	$146.37
82360		<1%	14	$139.13
86317		<1%	103	$135.73
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	4,009	$135.41
88341		<1%	1,199	$132.28
84520		<1%	857	$131.56
72020		<1%	13	$127.21
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	4,879	$111.46
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	25	$105.72
J2060	Injection, lorazepam, 2 mg	<1%	5,413	$104.29
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	6,280	$100.80
J1644	Injection, heparin sodium, per 1000 units	<1%	13,034	$95.05
J0780	Injection, prochlorperazine, up to 10 mg	<1%	2,583	$95.02
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	5,246	$93.90
J0690	Injection, cefazolin sodium, 500 mg	<1%	11,548	$84.65
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,464	$77.25
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	94	$75.00
88112		<1%	14	$72.97
76376		<1%	422	$67.87
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	18	$62.51
86780		<1%	85	$62.08
87075		<1%	452	$61.72
90723		<1%	3,401	$58.94
51703		<1%	14	$56.86
C1769	Guide wire	<1%	4,112	$56.54
99406		<1%	690	$55.29
82140		<1%	106	$54.45
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	15,508	$52.96
87324		<1%	83	$52.44
C1776	Joint device (implantable)	<1%	104	$44.92
J1940	Injection, furosemide, up to 20 mg	<1%	2,699	$37.44
93356		<1%	471	$36.69
91301		<1%	419	$36.30
87449		<1%	96	$31.92
89050		<1%	56	$29.78
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	3,247	$25.93
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	2,625	$23.17
72070		<1%	25	$22.60
36600		<1%	113	$21.68
87184		<1%	207	$20.42
72220		<1%	13	$20.40
J3370	Injection, vancomycin hcl, 500 mg	<1%	2,627	$19.36
A4648	Tissue marker, implantable, any type, each	<1%	316	$18.35
90672		<1%	93	$16.34
94760		<1%	1,844	$16.04
J1953	Injection, levetiracetam, 10 mg	<1%	334	$15.77
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	147	$12.00
80305		<1%	14	$8.51
82948		<1%	44	$7.83
86703		<1%	80	$7.16
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	3,156	$7.04
J1630	Injection, haloperidol, up to 5 mg	<1%	1,040	$5.71
82310		<1%	60	$5.29
G0008	Administration of influenza virus vaccine	<1%	5,300	$4.80
90653		<1%	383	$4.44
A9270	Non-covered item or service	<1%	95,009	$4.19
C9113	Injection, pantoprazole sodium, per vial	<1%	2,687	$4.09
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,040	$3.86
J1790	Injection, droperidol, up to 5 mg	<1%	121	$3.54
82435		<1%	60	$3.51
82374		<1%	60	$3.51
84295		<1%	61	$3.51
J3411	Injection, thiamine hcl, 100 mg	<1%	351	$3.06
J1836	Injection, metronidazole, 10 mg	<1%	153	$2.95
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	689	$2.36
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	395	$2.28
C1758	Catheter, ureteral	<1%	36	$2.09
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	1,281	$1.84
84075		<1%	42	$1.73
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	534	$1.59
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,546	$1.36
J3360	Injection, diazepam, up to 5 mg	<1%	161	$1.30
87807		<1%	348	$1.28
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,957	$0.90
J1650	Injection, enoxaparin sodium, 10 mg	<1%	4,460	$0.86
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	636	$0.77
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	468	$0.77
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	146	$0.70
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	1,075	$0.36
Q0222	Injection, bebtelovimab, 175 mg	<1%	75	$0.30
J1171	Injection, hydromorphone, 0.1 mg	<1%	377	$0.24
Q0243	Injection, casirivimab and imdevimab, 2400 mg	<1%	69	$0.17
J3480	Injection, potassium chloride, per 2 meq	<1%	1,541	$0.13
J0735	Injection, clonidine hydrochloride, 1 mg	<1%	100	$0.02
91307		0%	959	$0.00
J1920	Injection, labetalol hydrochloride, 5 mg	0%	125	$0.00
90619		0%	838	$0.00
96411		0%	692	$0.00
90696		0%	1,572	$0.00
90697		0%	1,435	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	848	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	1,541	$0.00
91314		0%	51	$0.00
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	0%	278	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	54	$0.00
D1208	Topical application of fluoride, excluding varnish	0%	37	$0.00
91305		0%	946	$0.00
82043		0%	90	$0.00
G0009	Administration of pneumococcal vaccine	0%	523	$0.00
91306		0%	496	$0.00
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	0%	449	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	163	$0.00
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	0%	412	$0.00
87486		0%	88	$0.00
J1815	Injection, insulin, per 5 units	0%	139	$0.00
C1781	Mesh (implantable)	0%	195	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	891	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	115	$0.00
J9045	Injection, carboplatin, 50 mg	0%	102	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	379	$0.00
95911		0%	38	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	139	$0.00
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	449	$0.00
85651		0%	64	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	213	$0.00
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	0%	239	$0.00
87046		0%	13	$0.00
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	287	$0.00
96368		0%	215	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	12	$0.00
87581		0%	88	$0.00
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	0%	60	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	69	$0.00
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	0%	13	$0.00
90744		0%	17	$0.00
86803		0%	33	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	95	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	18	$0.00
G0379	Direct admission of patient for hospital observation care	0%	13	$0.00
90381		0%	19	$0.00
C9399	Unclassified drugs or biologicals	0%	12	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	697	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	608	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	315	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	293	$0.00
90681		0%	3,014	$0.00
J1956	Injection, levofloxacin, 250 mg	0%	344	$0.00
91300		0%	850	$0.00
J3260	Injection, tobramycin sulfate, up to 80 mg	0%	80	$0.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	140	$0.00
91313		0%	691	$0.00
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	0%	133	$0.00
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	0%	23	$0.00
C1874	Stent, coated/covered, with delivery system	0%	137	$0.00
G0498	Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion	0%	70	$0.00
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	0%	248	$0.00
90473		0%	56	$0.00
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	0%	12	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	393	$0.00
87045		0%	13	$0.00
88313		0%	49	$0.00
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	0%	48	$0.00
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	140	$0.00
83970		0%	14	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	261	$0.00
91311		0%	112	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	49	$0.00
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	0%	16	$0.00
89051		0%	29	$0.00
31720		0%	43	$0.00
88173		0%	30	$0.00
87427		0%	20	$0.00
J3105	Injection, terbutaline sulfate, up to 1 mg	0%	27	$0.00
91312		0%	412	$0.00
85384		0%	13	$0.00
16020		0%	13	$0.00
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	0%	45	$0.00
88360		0%	46	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	18	$0.00
98927		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGRINNELL, JEANNINE (CHIEF FINANCIAL OFFICER)